Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank M Longo

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 29, 2013
A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's diseaseDanielle A Simmons, Nadia P Belichenko, Tao Yang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2002
Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formationManuel Buttini, Gui-Qiu Yu, Kristina Shockley, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 26, 2021
Establishing a Data Science Unit in an Academic Medical Center: An Illustrative ModelManisha Desai, Mary Boulos, Gina M Pomann, et al.
Frontiers in Neuroscience|July 18, 2019
Nerve Growth Factor Pathobiology During the Progression of Alzheimer's DiseaseElliott J Mufson, Scott E Counts, Stephen D Ginsberg, et al.
Neuropharmacology|June 24, 2016
A small molecule TrkB/TrkC neurotrophin receptor co-activator with distinctive effects on neuronal survival and process outgrowthTao Yang, Stephen M Massa, Kevin C Tran, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysisGregory A Cary, Stephen Keegan, Jesse C Wiley, et al.
The Journal of Sexual Medicine|November 27, 2020
Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve InjuryGuo Nan Yin, Jiyeon Ock, Anita Limanjaya, et al.
Brain : a Journal of Neurology|March 4, 2025
p75NTR modulation prevents cellular, cortical activity and cognitive dysfunctions caused by perinatal hypoxiaBidisha Chattopadhyaya, Karen K Y Lee, Maria Isabel Carreño-Muñoz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Neuron|November 1, 2002
ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injuryMichael S Beattie, Anthony W Harrington, Ramee Lee, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 29, 2013
A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's diseaseDanielle A Simmons, Nadia P Belichenko, Tao Yang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2002
Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formationManuel Buttini, Gui-Qiu Yu, Kristina Shockley, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 26, 2021
Establishing a Data Science Unit in an Academic Medical Center: An Illustrative ModelManisha Desai, Mary Boulos, Gina M Pomann, et al.
Frontiers in Neuroscience|July 18, 2019
Nerve Growth Factor Pathobiology During the Progression of Alzheimer's DiseaseElliott J Mufson, Scott E Counts, Stephen D Ginsberg, et al.
Neuropharmacology|June 24, 2016
A small molecule TrkB/TrkC neurotrophin receptor co-activator with distinctive effects on neuronal survival and process outgrowthTao Yang, Stephen M Massa, Kevin C Tran, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysisGregory A Cary, Stephen Keegan, Jesse C Wiley, et al.
The Journal of Sexual Medicine|November 27, 2020
Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve InjuryGuo Nan Yin, Jiyeon Ock, Anita Limanjaya, et al.
Brain : a Journal of Neurology|March 4, 2025
p75NTR modulation prevents cellular, cortical activity and cognitive dysfunctions caused by perinatal hypoxiaBidisha Chattopadhyaya, Karen K Y Lee, Maria Isabel Carreño-Muñoz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Neuron|November 1, 2002
ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injuryMichael S Beattie, Anthony W Harrington, Ramee Lee, et al.
Pageof 11